Botulinum Toxin Type A for Trigeminal Neuralgia: A Comprehensive Literature Review Article Swipe
Yan Tereshko
,
Simone Dal Bello
,
Christian Lettieri
,
Enrico Belgrado
,
Gian Luigi Gigli
,
Giovanni Merlino
,
Mariarosaria Valente
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.3390/toxins16110500
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.3390/toxins16110500
Trigeminal neuralgia is a neuropathic pain syndrome responsive to botulinum toxin type A therapy. This review had the goal of analyzing the different studies published from 2002 to January 2024 to better define the techniques and the types of botulinum toxin type A used, the doses, the injection routes, and the different populations of trigeminal neuralgia patients treated. We considered only articles in which the therapy was administered to humans to treat trigeminal neuralgia. Case reports, case series, open-label, retrospective, and RCT studies were considered. The research was conducted on MEDLINE and the keywords included (trigeminal neuralgia) and (botulinum). Thirty-five articles were considered suitable for this review. Botulinum toxin type A was shown to be an effective therapy for TN pain in all the articles analyzed, albeit there is a lack of standardization in methods and outcomes. The techniques, the doses, and the injection approaches were very heterogeneous among the studies. Only two botulinum toxin type A formulations have been used in this setting: onabotulinumtoxinA and lanbotulinumtoxinA. There were 300 patients treated with onabotulinumtoxinA and 760 treated with lanbotulinumtoxinA overall (in 42 patients, the formulation was not specified). The distinction between etiological and clinical types of TN has been made by only a small portion of the studies. The main adverse event was transient facial asymmetry. Botulinum toxin type A is indeed a promising therapy that is clearly effective for trigeminal neuralgia. OnabotulinumtoxinA is the most common formulation used in Western countries; however, the meager sample of TN patients treated, and the lack of standardization are not sufficient for this therapy to be approved by the FDA or EMA. Indeed, more studies with standardized methods and larger samples are needed for this purpose.
Related Topics
Concepts
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.3390/toxins16110500
- OA Status
- gold
- Cited By
- 3
- References
- 130
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4404546060
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4404546060Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3390/toxins16110500Digital Object Identifier
- Title
-
Botulinum Toxin Type A for Trigeminal Neuralgia: A Comprehensive Literature ReviewWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-11-20Full publication date if available
- Authors
-
Yan Tereshko, Simone Dal Bello, Christian Lettieri, Enrico Belgrado, Gian Luigi Gigli, Giovanni Merlino, Mariarosaria ValenteList of authors in order
- Landing page
-
https://doi.org/10.3390/toxins16110500Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.3390/toxins16110500Direct OA link when available
- Concepts
-
Trigeminal neuralgia, Medicine, Botulinum toxin, Adverse effect, Neuropathic pain, Neuralgia, Anesthesia, Dermatology, Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3Per-year citation counts (last 5 years)
- References (count)
-
130Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4404546060 |
|---|---|
| doi | https://doi.org/10.3390/toxins16110500 |
| ids.doi | https://doi.org/10.3390/toxins16110500 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39591255 |
| ids.openalex | https://openalex.org/W4404546060 |
| fwci | 2.74742972 |
| mesh[0].qualifier_ui | Q000188 |
| mesh[0].descriptor_ui | D014277 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | drug therapy |
| mesh[0].descriptor_name | Trigeminal Neuralgia |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | Q000627 |
| mesh[2].descriptor_ui | D019274 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | therapeutic use |
| mesh[2].descriptor_name | Botulinum Toxins, Type A |
| mesh[3].qualifier_ui | Q000009 |
| mesh[3].descriptor_ui | D019274 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | adverse effects |
| mesh[3].descriptor_name | Botulinum Toxins, Type A |
| mesh[4].qualifier_ui | Q000008 |
| mesh[4].descriptor_ui | D019274 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | administration & dosage |
| mesh[4].descriptor_name | Botulinum Toxins, Type A |
| mesh[5].qualifier_ui | Q000627 |
| mesh[5].descriptor_ui | D009465 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | therapeutic use |
| mesh[5].descriptor_name | Neuromuscular Agents |
| mesh[6].qualifier_ui | Q000009 |
| mesh[6].descriptor_ui | D009465 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | adverse effects |
| mesh[6].descriptor_name | Neuromuscular Agents |
| mesh[7].qualifier_ui | Q000008 |
| mesh[7].descriptor_ui | D009465 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | administration & dosage |
| mesh[7].descriptor_name | Neuromuscular Agents |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D016896 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Treatment Outcome |
| mesh[9].qualifier_ui | Q000188 |
| mesh[9].descriptor_ui | D014277 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | drug therapy |
| mesh[9].descriptor_name | Trigeminal Neuralgia |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | Q000627 |
| mesh[11].descriptor_ui | D019274 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | therapeutic use |
| mesh[11].descriptor_name | Botulinum Toxins, Type A |
| mesh[12].qualifier_ui | Q000009 |
| mesh[12].descriptor_ui | D019274 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | adverse effects |
| mesh[12].descriptor_name | Botulinum Toxins, Type A |
| mesh[13].qualifier_ui | Q000008 |
| mesh[13].descriptor_ui | D019274 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | administration & dosage |
| mesh[13].descriptor_name | Botulinum Toxins, Type A |
| mesh[14].qualifier_ui | Q000627 |
| mesh[14].descriptor_ui | D009465 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | therapeutic use |
| mesh[14].descriptor_name | Neuromuscular Agents |
| mesh[15].qualifier_ui | Q000009 |
| mesh[15].descriptor_ui | D009465 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | adverse effects |
| mesh[15].descriptor_name | Neuromuscular Agents |
| mesh[16].qualifier_ui | Q000008 |
| mesh[16].descriptor_ui | D009465 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | administration & dosage |
| mesh[16].descriptor_name | Neuromuscular Agents |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D016896 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Treatment Outcome |
| mesh[18].qualifier_ui | Q000188 |
| mesh[18].descriptor_ui | D014277 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | drug therapy |
| mesh[18].descriptor_name | Trigeminal Neuralgia |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D006801 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Humans |
| mesh[20].qualifier_ui | Q000627 |
| mesh[20].descriptor_ui | D019274 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | therapeutic use |
| mesh[20].descriptor_name | Botulinum Toxins, Type A |
| mesh[21].qualifier_ui | Q000009 |
| mesh[21].descriptor_ui | D019274 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | adverse effects |
| mesh[21].descriptor_name | Botulinum Toxins, Type A |
| mesh[22].qualifier_ui | Q000008 |
| mesh[22].descriptor_ui | D019274 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | administration & dosage |
| mesh[22].descriptor_name | Botulinum Toxins, Type A |
| mesh[23].qualifier_ui | Q000627 |
| mesh[23].descriptor_ui | D009465 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | therapeutic use |
| mesh[23].descriptor_name | Neuromuscular Agents |
| mesh[24].qualifier_ui | Q000009 |
| mesh[24].descriptor_ui | D009465 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | adverse effects |
| mesh[24].descriptor_name | Neuromuscular Agents |
| mesh[25].qualifier_ui | Q000008 |
| mesh[25].descriptor_ui | D009465 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | administration & dosage |
| mesh[25].descriptor_name | Neuromuscular Agents |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D016896 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Treatment Outcome |
| mesh[27].qualifier_ui | Q000188 |
| mesh[27].descriptor_ui | D014277 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | drug therapy |
| mesh[27].descriptor_name | Trigeminal Neuralgia |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D006801 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Humans |
| mesh[29].qualifier_ui | Q000627 |
| mesh[29].descriptor_ui | D019274 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | therapeutic use |
| mesh[29].descriptor_name | Botulinum Toxins, Type A |
| mesh[30].qualifier_ui | Q000009 |
| mesh[30].descriptor_ui | D019274 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | adverse effects |
| mesh[30].descriptor_name | Botulinum Toxins, Type A |
| mesh[31].qualifier_ui | Q000008 |
| mesh[31].descriptor_ui | D019274 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | administration & dosage |
| mesh[31].descriptor_name | Botulinum Toxins, Type A |
| mesh[32].qualifier_ui | Q000627 |
| mesh[32].descriptor_ui | D009465 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | therapeutic use |
| mesh[32].descriptor_name | Neuromuscular Agents |
| mesh[33].qualifier_ui | Q000009 |
| mesh[33].descriptor_ui | D009465 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | adverse effects |
| mesh[33].descriptor_name | Neuromuscular Agents |
| mesh[34].qualifier_ui | Q000008 |
| mesh[34].descriptor_ui | D009465 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | administration & dosage |
| mesh[34].descriptor_name | Neuromuscular Agents |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D016896 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Treatment Outcome |
| mesh[36].qualifier_ui | Q000188 |
| mesh[36].descriptor_ui | D014277 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | drug therapy |
| mesh[36].descriptor_name | Trigeminal Neuralgia |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D006801 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Humans |
| mesh[38].qualifier_ui | Q000627 |
| mesh[38].descriptor_ui | D019274 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | therapeutic use |
| mesh[38].descriptor_name | Botulinum Toxins, Type A |
| mesh[39].qualifier_ui | Q000009 |
| mesh[39].descriptor_ui | D019274 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | adverse effects |
| mesh[39].descriptor_name | Botulinum Toxins, Type A |
| mesh[40].qualifier_ui | Q000008 |
| mesh[40].descriptor_ui | D019274 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | administration & dosage |
| mesh[40].descriptor_name | Botulinum Toxins, Type A |
| mesh[41].qualifier_ui | Q000627 |
| mesh[41].descriptor_ui | D009465 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | therapeutic use |
| mesh[41].descriptor_name | Neuromuscular Agents |
| mesh[42].qualifier_ui | Q000009 |
| mesh[42].descriptor_ui | D009465 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | adverse effects |
| mesh[42].descriptor_name | Neuromuscular Agents |
| mesh[43].qualifier_ui | Q000008 |
| mesh[43].descriptor_ui | D009465 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | administration & dosage |
| mesh[43].descriptor_name | Neuromuscular Agents |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D016896 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Treatment Outcome |
| type | review |
| title | Botulinum Toxin Type A for Trigeminal Neuralgia: A Comprehensive Literature Review |
| biblio.issue | 11 |
| biblio.volume | 16 |
| biblio.last_page | 500 |
| biblio.first_page | 500 |
| topics[0].id | https://openalex.org/T12193 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Trigeminal Neuralgia and Treatments |
| topics[1].id | https://openalex.org/T11274 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9997000098228455 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2728 |
| topics[1].subfield.display_name | Neurology |
| topics[1].display_name | Botulinum Toxin and Related Neurological Disorders |
| topics[2].id | https://openalex.org/T12301 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9908000230789185 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2728 |
| topics[2].subfield.display_name | Neurology |
| topics[2].display_name | Facial Nerve Paralysis Treatment and Research |
| is_xpac | False |
| apc_list.value | 2400 |
| apc_list.currency | CHF |
| apc_list.value_usd | 2598 |
| apc_paid.value | 2400 |
| apc_paid.currency | CHF |
| apc_paid.value_usd | 2598 |
| concepts[0].id | https://openalex.org/C2780355897 |
| concepts[0].level | 2 |
| concepts[0].score | 0.9192705154418945 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1132120 |
| concepts[0].display_name | Trigeminal neuralgia |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.8690951466560364 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2777478456 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6394643783569336 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q208413 |
| concepts[2].display_name | Botulinum toxin |
| concepts[3].id | https://openalex.org/C197934379 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5878543853759766 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[3].display_name | Adverse effect |
| concepts[4].id | https://openalex.org/C2777107010 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5154839158058167 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2798704 |
| concepts[4].display_name | Neuropathic pain |
| concepts[5].id | https://openalex.org/C2780016216 |
| concepts[5].level | 3 |
| concepts[5].score | 0.48233339190483093 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1136940 |
| concepts[5].display_name | Neuralgia |
| concepts[6].id | https://openalex.org/C42219234 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4179896116256714 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q131130 |
| concepts[6].display_name | Anesthesia |
| concepts[7].id | https://openalex.org/C16005928 |
| concepts[7].level | 1 |
| concepts[7].score | 0.38271084427833557 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q171171 |
| concepts[7].display_name | Dermatology |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.175900399684906 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/trigeminal-neuralgia |
| keywords[0].score | 0.9192705154418945 |
| keywords[0].display_name | Trigeminal neuralgia |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.8690951466560364 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/botulinum-toxin |
| keywords[2].score | 0.6394643783569336 |
| keywords[2].display_name | Botulinum toxin |
| keywords[3].id | https://openalex.org/keywords/adverse-effect |
| keywords[3].score | 0.5878543853759766 |
| keywords[3].display_name | Adverse effect |
| keywords[4].id | https://openalex.org/keywords/neuropathic-pain |
| keywords[4].score | 0.5154839158058167 |
| keywords[4].display_name | Neuropathic pain |
| keywords[5].id | https://openalex.org/keywords/neuralgia |
| keywords[5].score | 0.48233339190483093 |
| keywords[5].display_name | Neuralgia |
| keywords[6].id | https://openalex.org/keywords/anesthesia |
| keywords[6].score | 0.4179896116256714 |
| keywords[6].display_name | Anesthesia |
| keywords[7].id | https://openalex.org/keywords/dermatology |
| keywords[7].score | 0.38271084427833557 |
| keywords[7].display_name | Dermatology |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.175900399684906 |
| keywords[8].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.3390/toxins16110500 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S128990672 |
| locations[0].source.issn | 2072-6651 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2072-6651 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Toxins |
| locations[0].source.host_organization | https://openalex.org/P4310310987 |
| locations[0].source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310310987 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Toxins |
| locations[0].landing_page_url | https://doi.org/10.3390/toxins16110500 |
| locations[1].id | pmid:39591255 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Toxins |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39591255 |
| locations[2].id | pmh:oai:doaj.org/article:9f7d28bdfc204070b551365c3eb11dbc |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Toxins, Vol 16, Iss 11, p 500 (2024) |
| locations[2].landing_page_url | https://doaj.org/article/9f7d28bdfc204070b551365c3eb11dbc |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11597931 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Toxins (Basel) |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11597931 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5045191745 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-4200-761X |
| authorships[0].author.display_name | Yan Tereshko |
| authorships[0].affiliations[0].raw_affiliation_string | Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Yan Tereshko |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy |
| authorships[1].author.id | https://openalex.org/A5015813814 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-2062-2547 |
| authorships[1].author.display_name | Simone Dal Bello |
| authorships[1].affiliations[0].raw_affiliation_string | Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Simone Dal Bello |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy |
| authorships[2].author.id | https://openalex.org/A5101625801 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0113-3887 |
| authorships[2].author.display_name | Christian Lettieri |
| authorships[2].affiliations[0].raw_affiliation_string | Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Christian Lettieri |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy |
| authorships[3].author.id | https://openalex.org/A5029618330 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Enrico Belgrado |
| authorships[3].affiliations[0].raw_affiliation_string | Neurology Unit, Udine University Hospital, Piazzale Santa Maria Della Misericordia 15, 33100 Udine, Italy |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Enrico Belgrado |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Neurology Unit, Udine University Hospital, Piazzale Santa Maria Della Misericordia 15, 33100 Udine, Italy |
| authorships[4].author.id | https://openalex.org/A5089052889 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-3526-1414 |
| authorships[4].author.display_name | Gian Luigi Gigli |
| authorships[4].countries | IT |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I129043915 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Medicine (DAME), University of Udine, Via Colugna 50, 33100 Udine, Italy |
| authorships[4].institutions[0].id | https://openalex.org/I129043915 |
| authorships[4].institutions[0].ror | https://ror.org/05ht0mh31 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I129043915 |
| authorships[4].institutions[0].country_code | IT |
| authorships[4].institutions[0].display_name | University of Udine |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Gian Luigi Gigli |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | Department of Medicine (DAME), University of Udine, Via Colugna 50, 33100 Udine, Italy |
| authorships[5].author.id | https://openalex.org/A5050488384 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6525-9529 |
| authorships[5].author.display_name | Giovanni Merlino |
| authorships[5].countries | IT |
| authorships[5].affiliations[0].raw_affiliation_string | Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I129043915 |
| authorships[5].affiliations[1].raw_affiliation_string | Department of Medicine (DAME), University of Udine, Via Colugna 50, 33100 Udine, Italy |
| authorships[5].institutions[0].id | https://openalex.org/I129043915 |
| authorships[5].institutions[0].ror | https://ror.org/05ht0mh31 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I129043915 |
| authorships[5].institutions[0].country_code | IT |
| authorships[5].institutions[0].display_name | University of Udine |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Giovanni Merlino |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy, Department of Medicine (DAME), University of Udine, Via Colugna 50, 33100 Udine, Italy |
| authorships[6].author.id | https://openalex.org/A5040134654 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6077-1315 |
| authorships[6].author.display_name | Mariarosaria Valente |
| authorships[6].countries | IT |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I129043915 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Medicine (DAME), University of Udine, Via Colugna 50, 33100 Udine, Italy |
| authorships[6].affiliations[1].raw_affiliation_string | Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy |
| authorships[6].institutions[0].id | https://openalex.org/I129043915 |
| authorships[6].institutions[0].ror | https://ror.org/05ht0mh31 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I129043915 |
| authorships[6].institutions[0].country_code | IT |
| authorships[6].institutions[0].display_name | University of Udine |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Mariarosaria Valente |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Clinical Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy, Department of Medicine (DAME), University of Udine, Via Colugna 50, 33100 Udine, Italy |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.3390/toxins16110500 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Botulinum Toxin Type A for Trigeminal Neuralgia: A Comprehensive Literature Review |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12193 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Trigeminal Neuralgia and Treatments |
| related_works | https://openalex.org/W2370623177, https://openalex.org/W4236631430, https://openalex.org/W4393376006, https://openalex.org/W2272755631, https://openalex.org/W2412703749, https://openalex.org/W2032849207, https://openalex.org/W4313318392, https://openalex.org/W2511918516, https://openalex.org/W2305187444, https://openalex.org/W4372291681 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3390/toxins16110500 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S128990672 |
| best_oa_location.source.issn | 2072-6651 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2072-6651 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Toxins |
| best_oa_location.source.host_organization | https://openalex.org/P4310310987 |
| best_oa_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Toxins |
| best_oa_location.landing_page_url | https://doi.org/10.3390/toxins16110500 |
| primary_location.id | doi:10.3390/toxins16110500 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S128990672 |
| primary_location.source.issn | 2072-6651 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2072-6651 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Toxins |
| primary_location.source.host_organization | https://openalex.org/P4310310987 |
| primary_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Toxins |
| primary_location.landing_page_url | https://doi.org/10.3390/toxins16110500 |
| publication_date | 2024-11-20 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4235264120, https://openalex.org/W2001819587, https://openalex.org/W2033952524, https://openalex.org/W2053310006, https://openalex.org/W2321711807, https://openalex.org/W1969107948, https://openalex.org/W2008634342, https://openalex.org/W4293877930, https://openalex.org/W2008929831, https://openalex.org/W1980446009, https://openalex.org/W2121518535, https://openalex.org/W2573952469, https://openalex.org/W2404719899, https://openalex.org/W2737267746, https://openalex.org/W2026634740, https://openalex.org/W2105065717, https://openalex.org/W2039254140, https://openalex.org/W1503275349, https://openalex.org/W2421930807, https://openalex.org/W2097000999, https://openalex.org/W1984144008, https://openalex.org/W2162024539, https://openalex.org/W2964633496, https://openalex.org/W2418113816, https://openalex.org/W4220728376, https://openalex.org/W2048843186, https://openalex.org/W1568215714, https://openalex.org/W2071921249, https://openalex.org/W2003940080, https://openalex.org/W1991378036, https://openalex.org/W2055070577, https://openalex.org/W2149512821, https://openalex.org/W2128585473, https://openalex.org/W1987143309, https://openalex.org/W2999828720, https://openalex.org/W2151785319, https://openalex.org/W4230845664, https://openalex.org/W6664062709, https://openalex.org/W2160122451, https://openalex.org/W2104850067, https://openalex.org/W1555111888, https://openalex.org/W2320288901, https://openalex.org/W6668311024, https://openalex.org/W2341310247, https://openalex.org/W1544060214, https://openalex.org/W2989041902, https://openalex.org/W4251015208, https://openalex.org/W1608538153, https://openalex.org/W2791937837, https://openalex.org/W2089213711, https://openalex.org/W2167719770, https://openalex.org/W4206211731, https://openalex.org/W2121437343, https://openalex.org/W2081753155, https://openalex.org/W2836914268, https://openalex.org/W2985340819, https://openalex.org/W2089753549, https://openalex.org/W7075700592, https://openalex.org/W2064501211, https://openalex.org/W1964696268, https://openalex.org/W2588581921, https://openalex.org/W2286625309, https://openalex.org/W2082021299, https://openalex.org/W318869472, https://openalex.org/W1562192869, https://openalex.org/W1982110862, https://openalex.org/W2165134984, https://openalex.org/W2021815265, https://openalex.org/W2153864564, https://openalex.org/W2009867382, https://openalex.org/W2153588448, https://openalex.org/W2769474684, https://openalex.org/W2073431285, https://openalex.org/W1983556734, https://openalex.org/W2030009013, https://openalex.org/W2076313213, https://openalex.org/W2794126114, https://openalex.org/W2064640591, https://openalex.org/W2607719947, https://openalex.org/W1987787053, https://openalex.org/W2073224536, https://openalex.org/W2111512122, https://openalex.org/W1966909918, https://openalex.org/W2030281720, https://openalex.org/W2552121607, https://openalex.org/W1984676594, https://openalex.org/W2074990877, https://openalex.org/W2035748022, https://openalex.org/W2019327068, https://openalex.org/W2140558584, https://openalex.org/W2010234123, https://openalex.org/W1542035530, https://openalex.org/W2006621588, https://openalex.org/W2077974102, https://openalex.org/W1966415657, https://openalex.org/W2129375020, https://openalex.org/W2142323737, https://openalex.org/W2315266178, https://openalex.org/W2135244205, https://openalex.org/W6713643661, https://openalex.org/W2011852775, https://openalex.org/W6717058066, https://openalex.org/W1663694435, https://openalex.org/W2300154459, https://openalex.org/W2745223142, https://openalex.org/W2803767291, https://openalex.org/W6745105408, https://openalex.org/W2795397949, https://openalex.org/W2790390460, https://openalex.org/W2963606701, https://openalex.org/W2961697916, https://openalex.org/W2969239051, https://openalex.org/W2975839736, https://openalex.org/W6767878648, https://openalex.org/W3038553759, https://openalex.org/W3183241417, https://openalex.org/W3198346145, https://openalex.org/W4310248647, https://openalex.org/W4308331700, https://openalex.org/W4386307360, https://openalex.org/W4388684251, https://openalex.org/W2965226820, https://openalex.org/W2063941975, https://openalex.org/W2068410234, https://openalex.org/W2587425064, https://openalex.org/W2766020134, https://openalex.org/W2048844807, https://openalex.org/W2972037298, https://openalex.org/W2053393211, https://openalex.org/W4404235013 |
| referenced_works_count | 130 |
| abstract_inverted_index.A | 12, 42, 110, 156, 219 |
| abstract_inverted_index.a | 3, 129, 202, 222 |
| abstract_inverted_index.42 | 181 |
| abstract_inverted_index.TN | 119, 196, 247 |
| abstract_inverted_index.We | 58 |
| abstract_inverted_index.an | 115 |
| abstract_inverted_index.be | 114, 262 |
| abstract_inverted_index.by | 200, 264 |
| abstract_inverted_index.in | 62, 121, 133, 161, 239 |
| abstract_inverted_index.is | 2, 128, 220, 226, 233 |
| abstract_inverted_index.of | 19, 38, 53, 131, 195, 205, 246, 253 |
| abstract_inverted_index.on | 89 |
| abstract_inverted_index.or | 267 |
| abstract_inverted_index.to | 8, 27, 30, 68, 70, 113, 261 |
| abstract_inverted_index.(in | 180 |
| abstract_inverted_index.300 | 169 |
| abstract_inverted_index.760 | 175 |
| abstract_inverted_index.FDA | 266 |
| abstract_inverted_index.RCT | 81 |
| abstract_inverted_index.The | 85, 137, 188, 208 |
| abstract_inverted_index.all | 122 |
| abstract_inverted_index.and | 35, 49, 80, 91, 97, 135, 141, 165, 174, 192, 250, 275 |
| abstract_inverted_index.are | 255, 278 |
| abstract_inverted_index.for | 104, 118, 229, 258, 280 |
| abstract_inverted_index.had | 16 |
| abstract_inverted_index.has | 197 |
| abstract_inverted_index.not | 186, 256 |
| abstract_inverted_index.the | 17, 21, 33, 36, 44, 46, 50, 64, 92, 123, 139, 142, 149, 183, 206, 234, 243, 251, 265 |
| abstract_inverted_index.two | 152 |
| abstract_inverted_index.was | 66, 87, 111, 185, 212 |
| abstract_inverted_index.2002 | 26 |
| abstract_inverted_index.2024 | 29 |
| abstract_inverted_index.Case | 74 |
| abstract_inverted_index.EMA. | 268 |
| abstract_inverted_index.Only | 151 |
| abstract_inverted_index.This | 14 |
| abstract_inverted_index.been | 159, 198 |
| abstract_inverted_index.case | 76 |
| abstract_inverted_index.from | 25 |
| abstract_inverted_index.goal | 18 |
| abstract_inverted_index.have | 158 |
| abstract_inverted_index.lack | 130, 252 |
| abstract_inverted_index.made | 199 |
| abstract_inverted_index.main | 209 |
| abstract_inverted_index.more | 270 |
| abstract_inverted_index.most | 235 |
| abstract_inverted_index.only | 60, 201 |
| abstract_inverted_index.pain | 5, 120 |
| abstract_inverted_index.that | 225 |
| abstract_inverted_index.this | 105, 162, 259, 281 |
| abstract_inverted_index.type | 11, 41, 109, 155, 218 |
| abstract_inverted_index.used | 160, 238 |
| abstract_inverted_index.very | 146 |
| abstract_inverted_index.were | 83, 101, 145, 168 |
| abstract_inverted_index.with | 172, 177, 272 |
| abstract_inverted_index.There | 167 |
| abstract_inverted_index.among | 148 |
| abstract_inverted_index.event | 211 |
| abstract_inverted_index.shown | 112 |
| abstract_inverted_index.small | 203 |
| abstract_inverted_index.there | 127 |
| abstract_inverted_index.toxin | 10, 40, 108, 154, 217 |
| abstract_inverted_index.treat | 71 |
| abstract_inverted_index.types | 37, 194 |
| abstract_inverted_index.used, | 43 |
| abstract_inverted_index.which | 63 |
| abstract_inverted_index.albeit | 126 |
| abstract_inverted_index.better | 31 |
| abstract_inverted_index.common | 236 |
| abstract_inverted_index.define | 32 |
| abstract_inverted_index.doses, | 45, 140 |
| abstract_inverted_index.facial | 214 |
| abstract_inverted_index.humans | 69 |
| abstract_inverted_index.indeed | 221 |
| abstract_inverted_index.larger | 276 |
| abstract_inverted_index.meager | 244 |
| abstract_inverted_index.needed | 279 |
| abstract_inverted_index.review | 15 |
| abstract_inverted_index.sample | 245 |
| abstract_inverted_index.Indeed, | 269 |
| abstract_inverted_index.January | 28 |
| abstract_inverted_index.MEDLINE | 90 |
| abstract_inverted_index.Western | 240 |
| abstract_inverted_index.adverse | 210 |
| abstract_inverted_index.between | 190 |
| abstract_inverted_index.clearly | 227 |
| abstract_inverted_index.methods | 134, 274 |
| abstract_inverted_index.overall | 179 |
| abstract_inverted_index.portion | 204 |
| abstract_inverted_index.review. | 106 |
| abstract_inverted_index.routes, | 48 |
| abstract_inverted_index.samples | 277 |
| abstract_inverted_index.series, | 77 |
| abstract_inverted_index.studies | 23, 82, 271 |
| abstract_inverted_index.therapy | 65, 117, 224, 260 |
| abstract_inverted_index.treated | 171, 176 |
| abstract_inverted_index.approved | 263 |
| abstract_inverted_index.articles | 61, 100, 124 |
| abstract_inverted_index.clinical | 193 |
| abstract_inverted_index.however, | 242 |
| abstract_inverted_index.included | 94 |
| abstract_inverted_index.keywords | 93 |
| abstract_inverted_index.patients | 56, 170, 248 |
| abstract_inverted_index.purpose. | 282 |
| abstract_inverted_index.reports, | 75 |
| abstract_inverted_index.research | 86 |
| abstract_inverted_index.setting: | 163 |
| abstract_inverted_index.studies. | 150, 207 |
| abstract_inverted_index.suitable | 103 |
| abstract_inverted_index.syndrome | 6 |
| abstract_inverted_index.therapy. | 13 |
| abstract_inverted_index.treated, | 249 |
| abstract_inverted_index.treated. | 57 |
| abstract_inverted_index.Botulinum | 107, 216 |
| abstract_inverted_index.analyzed, | 125 |
| abstract_inverted_index.analyzing | 20 |
| abstract_inverted_index.botulinum | 9, 39, 153 |
| abstract_inverted_index.conducted | 88 |
| abstract_inverted_index.different | 22, 51 |
| abstract_inverted_index.effective | 116, 228 |
| abstract_inverted_index.injection | 47, 143 |
| abstract_inverted_index.neuralgia | 1, 55 |
| abstract_inverted_index.outcomes. | 136 |
| abstract_inverted_index.patients, | 182 |
| abstract_inverted_index.promising | 223 |
| abstract_inverted_index.published | 24 |
| abstract_inverted_index.transient | 213 |
| abstract_inverted_index.Trigeminal | 0 |
| abstract_inverted_index.approaches | 144 |
| abstract_inverted_index.asymmetry. | 215 |
| abstract_inverted_index.considered | 59, 102 |
| abstract_inverted_index.countries; | 241 |
| abstract_inverted_index.neuralgia) | 96 |
| abstract_inverted_index.neuralgia. | 73, 231 |
| abstract_inverted_index.responsive | 7 |
| abstract_inverted_index.sufficient | 257 |
| abstract_inverted_index.techniques | 34 |
| abstract_inverted_index.trigeminal | 54, 72, 230 |
| abstract_inverted_index.(trigeminal | 95 |
| abstract_inverted_index.Thirty-five | 99 |
| abstract_inverted_index.considered. | 84 |
| abstract_inverted_index.distinction | 189 |
| abstract_inverted_index.etiological | 191 |
| abstract_inverted_index.formulation | 184, 237 |
| abstract_inverted_index.neuropathic | 4 |
| abstract_inverted_index.open-label, | 78 |
| abstract_inverted_index.populations | 52 |
| abstract_inverted_index.specified). | 187 |
| abstract_inverted_index.techniques, | 138 |
| abstract_inverted_index.(botulinum). | 98 |
| abstract_inverted_index.administered | 67 |
| abstract_inverted_index.formulations | 157 |
| abstract_inverted_index.standardized | 273 |
| abstract_inverted_index.heterogeneous | 147 |
| abstract_inverted_index.retrospective, | 79 |
| abstract_inverted_index.standardization | 132, 254 |
| abstract_inverted_index.OnabotulinumtoxinA | 232 |
| abstract_inverted_index.lanbotulinumtoxinA | 178 |
| abstract_inverted_index.onabotulinumtoxinA | 164, 173 |
| abstract_inverted_index.lanbotulinumtoxinA. | 166 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 97 |
| corresponding_author_ids | https://openalex.org/A5089052889 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I129043915 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/17 |
| sustainable_development_goals[0].score | 0.4699999988079071 |
| sustainable_development_goals[0].display_name | Partnerships for the goals |
| citation_normalized_percentile.value | 0.8586658 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |